Atul Deodhar Selected Research

Antigen-Antibody Complex (Immune Complex)

1/2022	Tofacitinib for the treatment of active ankylosing spondylitis in adults.
8/2002	Vasculitis secondary to staphylococcal Protein A immunoadsorption (Prosorba column) treatment in rheumatoid arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Atul Deodhar Research Topics

Disease

81	Ankylosing Spondylitis 05/2024 - 09/2008
39	Axial Spondyloarthritis 04/2024 - 06/2014
38	Psoriatic Arthritis 05/2024 - 10/2013
21	Non-Radiographic Axial Spondyloarthritis 05/2024 - 01/2016
20	Inflammation (Inflammations) 05/2024 - 07/2013
14	Rheumatoid Arthritis 05/2024 - 08/2002
13	Necrosis 11/2022 - 01/2008
12	Pain (Aches) 05/2024 - 12/2014
12	Sacroiliitis 05/2024 - 01/2016
12	Infections 10/2023 - 08/2008
11	Fatigue 03/2024 - 08/2009
11	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2024 - 10/2014
9	Arthritis (Polyarthritis) 03/2021 - 06/2014
7	Neoplasms (Cancer) 05/2024 - 01/2018
6	Back Pain (Backache) 06/2023 - 01/2016
5	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 05/2024 - 10/2014
5	Opportunistic Infections (Opportunistic Infection) 05/2024 - 01/2021
5	Chronic Disease (Chronic Diseases) 03/2024 - 01/2021
4	Nasopharyngitis 01/2023 - 01/2018
3	Skin Neoplasms (Skin Cancer) 05/2024 - 01/2018
3	Melanoma (Melanoma, Malignant) 05/2024 - 01/2018
3	Tuberculosis (Tuberculoses) 10/2023 - 01/2022
3	Crohn Disease (Crohn's Disease) 10/2023 - 12/2015
3	Herpes Zoster 01/2023 - 01/2021
3	Uveitis 03/2021 - 10/2014
2	Venous Thromboembolism 05/2024 - 11/2022
2	Rheumatic Diseases (Rheumatism) 03/2024 - 08/2022
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2023 - 01/2018
2	Ankylosis 12/2022 - 12/2017
2	Anterior Uveitis 12/2022 - 01/2021
2	COVID-19 09/2022 - 08/2022
2	Neutropenia 01/2022 - 12/2015
2	Candidiasis (Moniliasis) 12/2018 - 12/2015
2	Spondylarthropathies 01/2018 - 12/2017
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2017 - 10/2014
2	Iritis 02/2016 - 02/2016
2	Vasculitis (Vasculitides) 08/2014 - 08/2002
2	Fibromyalgia (Fibrositis) 04/2009 - 05/2002
1	Cardiovascular Diseases (Cardiovascular Disease) 05/2024
1	Spondylarthritis (Spinal Arthritis) 03/2024
1	Ulcerative Colitis 10/2023
1	Acquired Immunodeficiency Syndrome (AIDS) 07/2023
1	Pharyngitis (Sore Throat) 01/2023

Drug/Important Bio-Agent (IBA)

28	Tumor Necrosis Factor InhibitorsIBA 05/2024 - 06/2014
25	C-Reactive ProteinIBA 05/2024 - 08/2009
24	secukinumabIBA 03/2024 - 01/2015
21	Antirheumatic Agents (DMARD)IBA 03/2024 - 01/2015
19	golimumab FDA Link 08/2023 - 09/2010
18	ixekizumabIBA 02/2024 - 01/2018
17	guselkumabIBA 03/2024 - 01/2018
15	Interleukin-17 (Interleukin 17)IBA 05/2024 - 10/2014
14	Monoclonal AntibodiesIBA 12/2022 - 06/2014
13	upadacitinibIBA 05/2024 - 12/2019
10	Certolizumab Pegol FDA Link 05/2024 - 01/2016
9	Etanercept (Enbrel)FDA Link 01/2023 - 08/2002
9	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2022 - 01/2008
8	Adalimumab (Humira)FDA Link 03/2024 - 01/2008
8	InterleukinsIBA 01/2024 - 01/2018
7	bimekizumabIBA 04/2024 - 01/2020
7	Interleukin-23 (Interleukin 23)IBA 01/2024 - 01/2018
7	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2022 - 02/2016
6	tofacitinibIBA 05/2024 - 08/2017
6	Janus Kinase InhibitorsIBA 01/2023 - 08/2017
5	Infliximab (Remicade)FDA Link 11/2021 - 01/2008
5	Rituximab (Mabthera)FDA Link 05/2017 - 08/2008
4	omega-Chloroacetophenone (Mace)IBA 05/2024 - 01/2022
4	HLA-B27 Antigen (HLA B27 Antigen)IBA 07/2023 - 06/2011
4	CytokinesIBA 01/2022 - 01/2008
4	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 08/2002
3	Immunoglobulin A (IgA)IBA 01/2024 - 01/2022
3	Biomarkers (Surrogate Marker)IBA 01/2024 - 05/2012
3	HLA Antigens (Human Leukocyte Antigens)IBA 07/2023 - 10/2014
3	Interleukin-23 Subunit p19IBA 09/2022 - 01/2020
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 08/2009
3	belimumabIBA 10/2020 - 10/2014
3	GlucocorticoidsIBA 01/2019 - 02/2016
2	ametantrone (HAQ)IBA 03/2024 - 09/2022
2	Immunoglobulin G (IgG)IBA 10/2023 - 01/2022
2	Creatine Kinase (Creatine Phosphokinase)IBA 01/2023 - 12/2018
2	VaccinesIBA 08/2022 - 11/2021
2	Janus KinasesIBA 01/2022 - 01/2022
2	GLPG0634IBA 01/2022 - 12/2018
2	Antigen-Antibody Complex (Immune Complex)IBA 01/2022 - 08/2002
2	O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA 01/2022 - 03/2021
2	Proteins (Proteins, Gene)FDA Link 10/2020 - 07/2013
2	Sulfasalazine (Azulfidine)FDA LinkGeneric 10/2019 - 10/2019
2	Ustekinumab (CNTO 1275)FDA Link 01/2019 - 10/2014
2	Hemoglobins (Hemoglobin)IBA 12/2016 - 08/2009
2	Prednisone (Sone)FDA LinkGeneric 10/2014 - 08/2002
1	Biosimilar PharmaceuticalsIBA 03/2024
1	deucravacitinibIBA 03/2024
1	TYK2 Kinase (Tyrosine Kinase 2)IBA 03/2024
1	Genetic Markers (Genetic Marker)IBA 07/2023

Therapy/Procedure

27	Therapeutics 05/2024 - 08/2002
6	Biological Therapy 06/2023 - 05/2012
3	Subcutaneous Injections 10/2023 - 05/2012
3	Physical Therapy Modalities (Physical Therapy Technique) 03/2019 - 02/2016
2	Arthroplasty 02/2016 - 02/2016
1	Activities of Daily Living (ADL) 03/2024
1	Aftercare (After-Treatment) 03/2024